Coronavirus Notebook: EFPIA Attacks EU’s Vaccine Export Authorization Scheme, EMA Starts Rolling Review Of REGN-COV2 Antibody Combo
Executive Summary
Médecins Sans Frontières has urged Johnson & Johnson to prioritize vaccine supplies to COVAX, the EMA has clarified the dosing interval for Pfizer/BioNTech’s Comirnaty, and the UK has ordered more vaccine from Valneva.
You may also be interested in...
EU Tightens Criteria For Allowing COVID-19 Vaccine Exports
As the coronavirus crisis continues to worsen across Europe, the EU authorities have come up with a new way of determining whether exports of coronavirus vaccines should be allowed.
EMA Reviewing Two MAb Combinations For COVID-19
The European Medicines Agency's special review process that was used to help EU member states issue emergency use approvals for dexamethasone in COVID-19 patients is now being applied to two antibody combinations from Regeneron/Roche and Lilly.
EU Backs Down In Row Over AstraZeneca Vaccine Supplies
The European Commission has averted all-out conflict with AstraZeneca and the UK government, with good news from J&J and Pfizer/BioNTech easing supply concerns.